Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in JapanMitsuhiko Aiso, Naoya Sakamoto, Hajime Takikawa et al.|Hepatology Research|2018Cited by 61
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Shin Maeda, Shunji Hirose et al.|Hepatology Research|2020Cited by 38
Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo InfectionSusumu Hamada‐Tsutsumi, Yasuhito Tanaka, Etsuko Iio et al.|PLoS ONE|2015Cited by 26
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinibIlario Giovanni Rapposelli, Margherita Rimini, Toshifumi Tada et al.|Liver International|2021Cited by 25
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinomaIlario Giovanni Rapposelli, Andrea Casadei‐Gardini, Shigeo Shimose et al.|ESMO Open|2021Cited by 20